Radiofrequency ablation of Barrett's esophagus

European Surgery - Acta Chirurgica Austriaca

Volumn 41, Issue 1, 2009, Pages 19-25

  Arora, G ^a,b   Basra, S ^c   Roorda, A K ^d   Triadafilopoulos, George ^e  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

^d WEST VIRGINIA UNIVERSITY   (United States)

^e STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ablation; Barrett's; Radiofrequency

Indexed keywords

LANSOPRAZOLE; PROTON PUMP INHIBITOR;

BALLOON CATHETER; BARRETT ESOPHAGUS; DEVICE; DRUG MEGADOSE; ENDOSCOPIC THERAPY; ERADICATION THERAPY; ESOPHAGEAL PH MONITORING; ESOPHAGUS RESECTION; ESOPHAGUS STRICTURE; FOLLOW UP; GASTROINTESTINAL DYSPLASIA; HUMAN; OUTCOME ASSESSMENT; PATIENT SAFETY; RADIOFREQUENCY ABLATION; RECURRENCE RISK; REVIEW; STOMACH FUNDOPLICATION; SURVIVAL TIME; TREATMENT RESPONSE;

EID: 62249099945     PISSN: 16828631     EISSN: 16824016     Source Type: Journal    
DOI: 10.1007/s10353-009-0447-z     Document Type: Review

References (30)

1. Hirota WK, Loughney TM, Lazas DJ, Maydonovitch CL, Rholl V, Wong RK. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: Prevalence and clinical data. Gastroenterology 1999;116(2): 277-85
2. Cameron AJ, Zinsmeister AR, Ballard DJ, Carney JA. Prevalence of columnar-lined (Barrett's) esophagus. Comparison of population-based clinical and autopsy findings. Gastroenterology 1990;99(4):918-22
3. Kendall BJ, Whiteman DC. Temporal changes in the endoscopic frequency of new cases of Barrett's esophagus in an Australian health region. Am J Gastroenterol 2006;101(6): 1178-82
4. Kim SL, Waring JP, Spechler SJ, et al. Diagnostic inconsistencies in Barrett's esophagus. Department of Veterans Affairs Gastroesophageal Reflux Study Group. Gastroenterology 1994;107(4): 945-49
5. Crooks GW, Lichtenstein GR. Clinical implications of Barrett's esophagus. Arch Intern Med 1996;156(19):2174-80
6. Weston AP, Krmpotich PT, Cherian R, Dixon A, Topalosvki M. Prospective long-term endoscopic and histological follow-up of short segment Barrett's esophagus: Comparison with traditional long segment Barrett's esophagus. Am J Gastroenterol 1997;92(3):407-13
7. Sharma P, Morales TG, Bhattacharyya A, Garewal HS, Sampliner RE. Dysplasia in short-segment Barrett's esophagus: A prospective 3-year follow-up. Am J Gastroenterol 1997;92(11):2012-6
8. Sharma P, Falk GW, Weston AP, Reker D, Johnston M, Sampliner RE. Dysplasia and cancer in a large multicenter cohort of patients with Barrett's esophagus. Clin Gastroenterol Hepatol 2006;4(5):566-72
9. Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett's esophagus: A prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 1997;92(2):212-5
10. Rastogi A, Puli S, El-Serag HB, Bansal A, Wani S, Sharma P. Incidence of esophageal adenocarcinoma in patients with Barrett's esophagus and high-grade dysplasia: A meta-analysis. Gastrointest Endosc 2008;67(3):394-8
11. Conio M, Blanchi S, Lapertosa G, et al. Long-term endoscopic surveillance of patients with Barrett's esophagus. Incidence of dysplasia and adenocarcinoma: A prospective study. Am J Gastroenterol 2003;98(9):1931-9
12. Eckardt VF, Kanzler G, Bernhard G. Life expectancy and cancer risk in patients with Barrett's esophagus: A prospective controlled investigation. Am J Med 2001;111(1):33-7
13. Swisher SG, Deford L, Merriman KW, et al. Effect of operative volume on morbidity, mortality, and hospital use after esophagectomy for cancer. J Thorac Cardiovasc Surg 2000;119(6): 1126-32
14. Heitmiller RF, Redmond M, Hamilton SR. Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann Surg 1996;224(1):66-71
15. Schnell TG, Sontag SJ, Chejfec G, et al. Long-term nonsurgical management of Barrett's esophagus with high-grade dysplasia. Gastroenterology 2001;120(7):1607-19
16. Sampliner RE. Updated guidelines for the diagnosis, surveillance, and therapy of Barrett's esophagus. Am J Gastroenterol 2002;97(8):1888-95
17. Ganz RA, Utley DS, Stern RA, Jackson J, Batts KP, Termin P. Complete ablation of esophageal epithelium with a balloon-based bipolar electrode: A phased evaluation in the porcine and in the human esophagus. Gastrointest Endosc 2004;60(6):1002-10
18. Dunkin BJ, Martinez J, Bejarano PA, et al. Thin-layer ablation of human esophageal epithelium using a bipolar radiofrequency balloon device. Surg Endosc 2006;20(1):125-30
19. Smith CD, Bejarano PA, Melvin WS, Patti MG, Muthusamy R, Dunkin BJ. Endoscopic ablation of intestinal metaplasia containing high-grade dysplasia in esophagectomy patients using a balloon-based ablation system. Surg Endosc 2007;21(4):560-9
20. Fleischer DE, Overholt BF, Sharma VK, et al. Endoscopic ablation of Barrett's esophagus: A multicenter study with 2.5-year follow-up. Gastrointest Endosc 2008;68(5):867-76
21. Roorda AK, Marcus SN, Triadafilopoulos G. Early experience with radiofrequency energy ablation therapy for Barrett's esophagus with and without dysplasia. Dis Esophagus 2007;20(6):516-22
22. Ganz RA, Overholt BF, Sharma VK, et al. Circumferential ablation of Barrett's esophagus that contains high-grade dysplasia: A U.S. Multicenter Registry. Gastrointest Endosc 2008;68(1):35-40
23. Sharma VK, Kim HJ, Das A, Dean P, DePetris G, Fleischer DE. A prospective pilot trial of ablation of Barrett's esophagus with low-grade dysplasia using stepwise circumferential and focal ablation (HALO system). Endoscopy 2008;40(5):380-7
24. Gondrie JJ, Pouw RE, Sondermeijer CM, et al. Stepwise circumferential and focal ablation of Barrett's esophagus with high-grade dysplasia: results of the first prospective series of 11 patients. Endoscopy 2008;40(5):359-69
25. Gondrie JJ, Pouw RE, Sondermeijer CM, et al. Effective treatment of early Barrett's neoplasia with stepwise circumferential and focal ablation using the HALO system. Endoscopy 2008;40(5):370-9
26. Finkelstein SD, Lyday WD. The molecular pathology of radiofrequency mucosal ablation of Barrett's esophagus. Gastroenterology 2008;134(4):A-436 [Abstract]
27. Gondrie JJ, Rygiel AM, Sondermeijer C. Balloon-based circumferential ablation followed by focal ablation of Barrett's esophagus containing high-grade dysplasia effectively removes all genetic alterations. Gastroenterology 2007;S1(132):A-64 [Abstract]
28. Shaheen NJ, Sharma P, Overholt BF. A randomized, multicenter, sham-controlled trial of radiofrequency ablation for subjects with Barrett's esophagus containing dysplasia: Interim results of the AIM dysplasia trial. Gastroenterology 2008;134(4):S-1; A-37 [Abstract]
29. Sharma VK, Wang KK, Overholt BF, et al. Balloon-based, circumferential, endoscopic radiofrequency ablation of Barrett's esophagus: 1-year follow-up of 100 patients. Gastrointest Endosc 2007;65(2):185-95
30. Inadomi JM, Madanick RD. Radiofrequency ablation is more cost-effective than endoscopic surveillance or esophagectomy among patients with Barrett's esophagus and low-grade dysplasia. Gastroenterology 2007;S1(132):A-53 [Abstract]